Stay updated on Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Results data are now visible on the Study Details page, with the Results First Posted date listed as 2024-02-06, alongside outcome measures. This marks a shift from purely protocol content to published study results.
    Difference
    0.3%
    Check dated 2025-11-03T01:22:20.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    30 days ago
    Change Detected
    Summary
    Updated to v3.2.0 with a new clinical term added and a government-operating-status notice; older version note v3.1.0 removed.
    Difference
    2%
    Check dated 2025-10-05T10:16:01.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Page version updated to v3.1.0 and 'Diffuse large b-cell lymphoma' removed from the content; core page content likely updated without introducing new topics.
    Difference
    0.1%
    Check dated 2025-09-28T03:15:46.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Minor revision update: the page version is now v3.0.2 (was v3.0.1). The 'Back to Top' link was removed, with no other substantive core-content changes detected.
    Difference
    0.1%
    Check dated 2025-09-13T17:37:17.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.1%
    Check dated 2025-09-06T15:18:34.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, including specific cities in Italy and Spain, while also introducing new medical terms related to lymphomas and treatments. Notably, the previous versions of certain terms and locations have been removed.
    Difference
    3%
    Check dated 2025-08-30T11:57:44.000Z thumbnail image

Stay in the know with updates to Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.